Objectives: To determine the prevalence of vitamin D deficiency and growth parameters (short stature and underweight) in thalassemia major patients. Study Design: A cross-sectional, descriptive study. Place and Duration of Study: A cross-sectional, descriptive study was undertaken at the department of pediatrics, Lahore General Hospital/PGMI/AMC, Lahore from July 2020, to January 2021. Material and Methods: There were 136 confirmed cases of thalassemia major, ranging in age from 6 months to 15 years of both sexes. Children with co-existing other chronic medical conditions were excluded from the study. Severely primary malnourished and other patients who received calcium, phosphorus, and vitamin D supplementation were also excluded. Serum 25-OH vitamin D levels were measured using chemiluminescence. Patients were categorized as having short stature and underweight as per WHO growth parameters. Results: The study participants ranged in age from 6 months to 15 years, with a mean age of 7.68 ± 2.89 years. The male to female ratio was 1.1:1 among the 136 patients, with 72 (52.94 percent) males and 64 (47.06 percent) females. The prevalence of vitamin D deficiency, short stature, and underweight in thalassemia major patients was seen in this study in 23, 67, and 64 individuals, respectively. Conclusion: This study concluded that 17% of thalassemia major patients have a vitamin D deficiency and a large number of children had effects on their growth (short stature and underweight).